Presentation is loading. Please wait.

Presentation is loading. Please wait.

Monitoring and Evaluation issues related to Preventive Chemotherapy (LF and STH) Dr. S. K. Jain Joint Director & Head Department of Parasitic Diseases.

Similar presentations


Presentation on theme: "Monitoring and Evaluation issues related to Preventive Chemotherapy (LF and STH) Dr. S. K. Jain Joint Director & Head Department of Parasitic Diseases."— Presentation transcript:

1 Monitoring and Evaluation issues related to Preventive Chemotherapy (LF and STH) Dr. S. K. Jain Joint Director & Head Department of Parasitic Diseases National Centre for Disease Control Ministry of Health & FW India

2 NTDs in India India has made considerable progress in the control/ elimination and eradication of the NTDs. Guinea worm has been eradicated from the country February, 2000. Leprosy eliminated at National level (2005) Yaws eliminated in September, 2006. Moving towards LF and Kala Azar elimination

3 India- Population at Risk of LF Endemic districts: 255 (in 21 States/UTs) Population at risk: 600 million Population eligible for MDA – 509 Million

4 Indian Scenario 54 million infected (45% of global) 30.9 million mf carriers and 23.4 million diseased 16 states and 5 Union Territories 255 endemic districts About 800,000 lymphoedema and 400,000 hydrocele cases line listed

5 5 ELIMINATION OF LYMPHATIC FILARIASIS Elimination of LF : LF ceases to be a public health problem, when the number of microfilaria carriers is less than 1% and the children born after initiation of ELF are free from circulating antigenaemia Goal: The National Health Policy (2002) has set the goal of Elimination of Lymphatic Filariasis in India by 2015. Global goal to eliminate Lymphatic Filariasis (LF) as public health problem by 2020 through World Health Assembly resolution WHA 50.29.

6 ELF Programme  Programme initiated on a pilot basis in 13 districts during 1996– 97  Gradually scaled up to reach all the endemic districts  DEC + Albendazole since 2008. Strategies Strategies -  Interruption of transmission of filariasis by Annual MDA for 5 years or more using (DEC + Albendazole )  Morbidity Management  Home based management of lymphoedema cases  up-scaling of hydrocele operations

7 MDA Coverage vs Microfilaria Rate

8 Impact of MDA

9 Brief Roadmap 200 Districts with <1% mf rate 55 districts to reduce Mf Rate <1% 2012-13: 4 District cleared 2013-14: 9 districts cleared 2014-15: 15 Districts cleared & 40 in process 2015-16: 100 Proposed subject to availability of 200,000 ICT Cards Data analysis & Validation + surveillance MDA and Data analysis Validation through additional Mf survey Antegenemia Test in Phased manner 2015-16 onwards:10% of distt may require MDA due to poor compliance & Remaining to undergo Post MDA surveillance for 5-6 years

10 TAS in India TAS successful in 28 EUs in Goa, Pondicherry, Daman & Diu, Tamil Nadu, Karnataka, Maharashtra, West Bengal and Assam Training of Trainers (TOTs) - National level and at four regional level at Maharashtra, Odisha, Tamil Nadu, and Karnataka (139 officers trained) Most of the endemic states are in the process of preparing plans for TAS after fulfilling pre- TAS criteria i.e. where MDA has been undertaken more that 5- 6 rounds, mf rates 65%.

11 Initiatives of the Programme related to M&E Programme has taken necessary steps towards elimination Development of National Roadmap towards LF elimination Focussed approach in hot spots and districts still endemic for LF  Nationwide uniform campaign launched in 3 rd week of Dec 2014 in twelve states  90 million DEC tablets received from WHO facilitating MDA in high endemic districts  Involvement of partners (GNNTD) in advocacy & media campaign Focussed approach in districts eligible for TAS  74000 ICT tests received from WHO  5-6 regional TAS capacity building workshops planned- Feb 2015  National roadmap Considering vast area in Preparatory activities- In majority these were carried out, but the timelines have not been followed.

12 Initiatives of the Programme related to M&E National Vector Borne Directorate has undertaken joint monitoring mission (JMM- 2014) through National & International experts Independent appraisal of ELF programme completed through WHO collaborating centre (VCRC) year July-Aug 2014

13 Lymphatic Filariasis Joint Monitoring Mission revealed : Overall performance in filarial elimination is satisfactory except Bihar where regular observance of MDA and commitment towards elimination are serious concern. Assam, Odisha and West Bengal are on right track Tamil Nadu and Karnataka have almost achieved the prevalence of Mf rate of less than 1%. Uttar Pradesh has management problem like providing 70% of required DEC Filaria officers and District malaria officers are doing the job without coordination.

14 Lymphatic Filariasis -Recommendations Districts reporting more than 1% mf to Improve compliance Districts reporting less than 1% mf to do TAS Post MDA surveillance as per guidelines with 3 TAS Vector surveillance (i.e. xenomonitoring) The hot-spots to be under intensive surveillance for treatment and interventions Provision of Lymphoedema management services at PHCs and hydrocele operations at CHCs/ District Hospitals to be established under NHM Morbidity management to continue even after stoppage of MDA

15 Independent Appraisal-2014 in 6 states revealed: Bihar :Governance at state/distt level is crucial but grass root workers are aware and can improve Gujarat : showing impact but coordination in corporation and state Directorate needs attention for monitoring to tackle migratory population MP :Mf rate in certain blocks is high due to suboptimal performance Odisha : Priority affects performance in some areas (malaria is main priority) Telangana : high Mf rate in certain blocks reflects suboptimal performance West Bengal : Progressed well after video conferencing between Director NVBDCP & senior state/ district officers followed by letters

16 Soil Transmitted Helminths (STH) in India Within SEARO, 64% of the children who require deworming in this region are from India, 15% from Indonesia and 13% from Bangladesh In absolute numbers, 157,498,685 school age children require PC in India

17 Lack of National Database on STH Prevalence India is endemic for STH Vast country with diverse ecological zones and varying STH transmission dynamics Limited STH data throughout the country (Few States like Bihar, Delhi and Rajasthan have conducted independent surveys) None of the current National or Sub-national surveys like NFHS, DLHS, AHS, NNMB captures information on worm load. Need to understand prevalence and intensity of STH infections to: Guide treatment strategies. (annual / bi-annual / no ) Assess impact of program. There are no national guidelines to ensure technically appropriate and standardized strategies for mapping STH in India. ………..there is an urgent need for a National database for mapping of prevalence of worm infestation loads in India across all States/ UTs

18 STH prevalence survey (1972-1996)

19 STH prevalence survey 1999-2003

20

21 Deworming activities In India 11 States providing Albendazole bundled in Vitamin A to <5 children bi-annual rounds Albendazole under Lymphatic Filariasis programme – Annual Mass Drug Administration (MDA) of single dose of Albendazole with DEC – For 5 years or more to the eligible population (except pregnant women, children below 2 years of age and seriously ill persons) WIFS: Along with Weekly Iron Folic Acid Supplementation – Operational since 2012 – Bi-annual deworming – to all 11- 19 yr school going adolescents girls & boys and out-of-school adolescent girls Revised strategy under National Iron Plus Initiative, 2013- Children 1-19 years, women in Reproductive Age 20 – 49 years National Deworming Day 10th Feb 2015

22 Deworming

23 Recent survey In Jan 2015 among school children in a district Delhi Overall prevalence 30.96%. The prevalence of single infection: 26.72% (Ascaris), 1.9%(H.nana) & 0.76% (Trichuris) None of the sample was found positive for Ankylostoma. All Ascaris positive samples had epg values within the category of “light infection” (<5000 epg)

24 Monitoring Systems MDA programmes implemented to control soil-transmitted helminths (STH), are currently poorly monitored, and one of the main reasons for this lack of monitoring systems is the absence of a Plan of Action Work for National plan of action is currently underway The is no National Programme for STH – No sentinel sites – No data monitoring Whatever coverage data is available is through LF programme where Albendazole is being given along DEC As per last round of Deworming in Under-five children, the national coverage was 68.06 percent (data from LF programme for LF endemic districts)

25 Current update Series of meetings have been undertaken to address the STH related issues – Recently on 22 nd Dec 2014 Child Health Division, MoH is leading the deworming campaign Systematic coverage data & monitoring mechanisms to be laid down with National Plan of Action – Planned to be captured after introduction of National Deworming Day 2015 (10 th Feb 2015)

26 Thank you


Download ppt "Monitoring and Evaluation issues related to Preventive Chemotherapy (LF and STH) Dr. S. K. Jain Joint Director & Head Department of Parasitic Diseases."

Similar presentations


Ads by Google